Related references
Note: Only part of the references are listed.Developing a Novel Indium(III) Agent Based on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer by Multitargeting the Tumor Microenvironment Components
Ming Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis
Juzheng Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development
Petra Heffeter et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway
Faiz-Ur Rahman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway
Xuemei Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Discovery of Novel Bromophenol Thiosemicarbazone Hybrids as Potent Selective Inhibitors of Poly(ADP-ribose) Polymerase-1 (PARP-1) for Use in Cancer
Chuanlong Guo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine
Felisa Cilurzo et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety
Anna Mrozek-Wilczkiewicz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes
Rukhsana Anjum et al.
INORGANIC CHEMISTRY (2019)
Novel Brain-Tumor-Inhibiting Copper(II) Compound Based on a Human Serum Albumin (HSA)-Cell Penetrating Peptide Conjugate
Zhenlei Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia
Toshiro Saito et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in Cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents
Hanfang Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Palladium(II) complexes with thiosemicarbazones derived from pyrene as topoisomerase IB inhibitors
Carolina G. Oliveira et al.
DALTON TRANSACTIONS (2019)
Designing anticancer multitarget metal thiosemicarbazone prodrug based on the nature of binding sites of human serum albumin carrier
Feng Yang et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli
Brandon M. Hall et al.
AGING-US (2017)
Roles for RACK1 in cancer cell migration and invasion
Deirdre Duff et al.
CELLULAR SIGNALLING (2017)
Structure-Activity Relationships of Di-2-pyridylketone, 2-Benzoylpyridine, and 2-Acetylpyridine Thiosemicarbazones for Overcoming Pgp-Mediated Drug Resistance
Alexandra E. Stacy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Developing Anticancer Ferric Prodrugs Based on the N-Donor Residues of Human Serum Albumin Carrier IIA Subdomain
Jinxu Qi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC
Nicole A. Seebacher et al.
CELL DEATH & DISEASE (2016)
Mitotic Stress Is an Integral Part of the Oncogene-Induced Senescence Program that Promotes Multinucleation and Cell Cycle Arrest
Dina Dikovskaya et al.
CELL REPORTS (2015)
Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
Ting Chen et al.
CANCER BIOLOGY & THERAPY (2015)
The Cambridge Structural Database in Retrospect and Prospect
Colin R. Groom et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Particle Carriers for Combating Multidrug-Resistant Cancer
Yan Yan et al.
ACS NANO (2013)
Aryl- and Heteroaryl-Thiosemicarbazone Derivatives and Their Metal Complexes: A Pharmacological Template
Narayana S.H.N. Moorthy et al.
Recent Patents on Anti-Cancer Drug Discovery (2013)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II)
Haihua Xiao et al.
BIOMATERIALS (2011)
Role of Metalation in the Topoisomerase Ilα Inhibition and Antiproliferation Activity of a Series of α-Heterocyclic-N4-Substituted Thiosemicarbazones and Their Cu(II) Complexes
Brian M. Zeglis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Thiosemicarbazones: the new wave in cancer treatment
Danuta S. Kalinowski et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1
Helen H. W. Chen et al.
MOLECULAR PHARMACOLOGY (2008)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Design, synthesis, and characterization of novel iron chelators: Structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents
Danuta S. Kalinowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity
Des R. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Modifications of DNA by platinum complexes - Relation to resistance of tumors to platinum antitumor drugs
V Brabec et al.
DRUG RESISTANCE UPDATES (2005)
Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types
JM Kelm et al.
BIOTECHNOLOGY AND BIOENGINEERING (2003)
DNA repair and cisplatin resistance in non-small-cell lung cancer
R Rosell et al.
LUNG CANCER (2002)
Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells
JW Park et al.
CANCER LETTERS (2001)
Share Paper
